Smith & Nephew (SNN) Short-term Investments (2009 - 2025)
Smith & Nephew (SNN) posted quarterly Short-term Investments of $20.0 million for Q4 2025, down 57.45% year-on-year from $47.0 million in Q4 2024, and down 57.45% on a QoQ basis from $47.0 million in Q4 2024.
Smith & Nephew (SNN) Short-term Investments (2009 - 2025) Analysis & Trends
Smith & Nephew (SNN) has reported Short-term Investments for 16 consecutive years, with $20.0 million the latest figure, recorded in Q4 2025.
- Quarterly Short-term Investments fell 57.45% year-over-year to $20.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $20.0 million (down 57.45% YoY) and the FY2025 annual result came in at $20.0 million, down 57.45% from the prior year.
- Short-term Investments declined to $20.0 million in Q4 2025 per SNN's latest filing, from $47.0 million in the prior quarter.
- Over the last five years, Short-term Investments for SNN reached as high as $47.0 million in Q4 2022 and fell as low as $20.0 million in Q4 2025.
- A 5-year average of $36.0 million and a median of $39.0 million in 2021 frame the typical range for Short-term Investments.
- Annual changes were most pronounced in 2024 — Short-term Investments jumped 74.07% — and 2025, when it slumped 57.45%.
- Year by year, Short-term Investments stood at $39.0 million in 2021, then climbed by 20.51% to $47.0 million in 2022, then slumped by 42.55% to $27.0 million in 2023, then soared by 74.07% to $47.0 million in 2024, then sank by 57.45% to $20.0 million in 2025.
- According to Business Quant data, Short-term Investments over the past three periods registered $20.0 million, $47.0 million, and $27.0 million for Q4 2025, Q4 2024, and Q4 2023 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Steris | 20.59 Bn | 20.16 Bn | 697.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 20.00 Mn |
| Dec 31, 2024 | 47.00 Mn |
| Dec 31, 2023 | 27.00 Mn |
| Dec 31, 2022 | 47.00 Mn |
| Dec 31, 2021 | 39.00 Mn |
| Dec 31, 2020 | 24.00 Mn |
| Dec 31, 2019 | 26.00 Mn |
| Dec 31, 2018 | 37.00 Mn |
| Dec 31, 2017 | 28.00 Mn |
| Dec 31, 2016 | 48.00 Mn |
| Dec 31, 2015 | 33.00 Mn |
| Dec 31, 2013 | 2.00 Mn |
| Sep 28, 2013 | 2.00 Mn |
| Jun 29, 2013 | 2.00 Mn |
| Mar 31, 2013 | 2.00 Mn |
| Dec 31, 2012 | 2.00 Mn |
| Sep 29, 2012 | 167.00 Mn |
| Jun 30, 2012 | 165.00 Mn |
| Mar 31, 2012 | 4.00 Mn |
| Dec 31, 2011 | 4.00 Mn |